Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Other financing activities (2017 - 2025)

BioRestorative Therapies (BRTX) has disclosed Other financing activities for 7 consecutive years, with $39197.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other financing activities changed N/A year-over-year to $39197.0, compared with a TTM value of $270006.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $148697.0, up 1882.63% over the prior year.
  • Other financing activities was $39197.0 for Q2 2025 at BioRestorative Therapies, down from $182305.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $182305.0 in Q1 2025 and bottomed at $39197.0 in Q2 2025.
  • Average Other financing activities over 3 years is $98304.4, with a median of $72819.0 recorded in 2022.